AAD Annual Meeting In Brief
This article was originally published in The Rose Sheet
Executive Summary
Stiefel Launches OTC Acne Meds
You may also be interested in...
J&J Extends Leading Skin-Care Brands With Kits Featuring Cytomimic
Capitalizing on momentum in its skin-care business, Johnson & Johnson is introducing new Cytomimic technology to its Aveeno, Neutrogena and RoC brands with dual-product kits for anti-aging needs around the clock
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.